Improved control of seizures
Fycompa is indicated to treat partial-onset seizures in patients aged 12 years and older.
Diagnosis & Disease Information
FDA approves add-on epileptic seizure medication
Aptiom has been approved for adult patients with partial seizures who have not achieved satisfactory control with existing treatments.
Consider nocturnal seizures when evaluating a patient for parasomnias
Since health-care providers rarely see cases involving nocturnal seizures, it can easily be confused with parasomnias, including confusional arousals, cataplexy and REM sleep behavior disorder.
Differentiating between cataplexy and seizures
A policeman that has experienced several falls at work illustrates the cardinal symptom in narcolepsy.
Psuedoseizure dilemma
Clinician seeks advice on handling a patient with dramatic psuedoseizures that are provoked by nontoxic environmental stimuli.
FDA investigates febrile seizures after flu vaccine
VAERS detects increase in febrile seizures among children aged 2 years and younger vaccinated with Fluzone.
Soldier’s seizures mistakenly thought to be caused by poisonous powder
Physician assistant evaluation revealed disorder’s true source.
Throat pain causes a patient to divulge his lifelong secret
The man’s heretofore unknown neurologic condition calls the original diagnosis into question.
Adjunctive therapy for epilepsy
Vimpat is used in the treatment of partial-onset seizures.
- Loading...
Loading...
Next post in Drug Update
Loading... 
Loading...